Matching slides 118,471
Current window 87,031-87,060
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all

Component

87,031-87,060 of 118,471

filter-aware
27
The slide uses a checkmark matrix to highlight the competitive advantage of the company's lead asset against standard-of-care classes like SSRIs, SNRIs, and Benzodiazepines.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a map, metric callouts, and a vertical timeline-style list to quantify the market opportunity.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
The table uses checkmarks to indicate positive attributes for various therapies, highlighting DMX-1002's unique profile.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
44
The slide highlights that RL-007 reverses memory deficits at the lowest dose and outperforms the standard of care (Aricept).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
48
The slide highlights potential expansion beyond mental health into anti-inflammatory and other CNS-related therapeutic areas.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
49
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
07
Includes a flywheel diagram representing core values.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Situation & ContextLoop · Golden Circle1 hit
13
Azek | IPO Presentation Deck | 43 slidesAzek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Problem & Complication1 hit
14
The slide uses a 2x5 grid layout to showcase the leadership team.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Setup & Stakes1 hit
15
The slide uses a side-by-side comparison of resilience factors and specific crisis management actions.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Setup & Stakes1 hit
17
The slide uses a combination of bar charts for internal metrics and line charts for external market search trends to demonstrate growth.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Visualization1 hit
19
Uses a central circular diagram to illustrate the 'early innings' thesis, supported by market size and CAGR data for each segment.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · VisualizationLoop · Cost Of Inaction1 hit
20
The slide uses a combination of visual 'before/after' imagery and stacked bar charts to demonstrate value.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · VisualizationLoop · Cost Of Inaction1 hit
25
The slide uses a visual 'house' diagram to map specific product categories to their real-world application points.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
26
Uses a pyramid diagram to illustrate the market structure and a list to detail specific barriers.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
28
The slide uses a stepped process diagram to illustrate growth drivers.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
29
The slide uses a timeline structure to map specific product launches to quarters, anchored by a central strategy box.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Satisfaction1 hit
31
The slide uses a donut chart to show market segmentation and a funnel-like graphic to represent driving results through retail partners.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Satisfaction1 hit
32
The slide uses a combination of a process flow and a timeline-based bar chart to illustrate the impact of AIMS and recycling initiatives on margins.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Satisfaction1 hit
38
Includes explanatory callouts for performance drivers and a disclaimer regarding the preliminary nature of the data.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
39
Includes a table showing pre-IPO and post-IPO pro forma debt levels and credit statistics.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
40
Includes two conceptual 'equations' represented as additive block diagrams.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
43
Contains four distinct financial reconciliation tables with detailed footnotes.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
01
Slide 1
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
04
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Team1 hit
06
The slide uses a Gantt-style chart to show clinical trial phases.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
08
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Problem1 hit
22
The slide uses a two-column layout to contrast market opportunity with the societal cost of the disease.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
28
The slide highlights the lack of targeted anti-inflammatory therapies for PBC.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
35
The table shows percentage changes or values for various renal markers. The 16mg dose consistently shows stronger efficacy (higher percentage reductions in protein/albumin) compared to 8mg.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit